AVAlan W. Varley

Alan W. Varley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan W. Varley has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Baomei Shao

    Department of Internal Medicine, Division of Infectious Diseases, The University of Texas Southwestern Medical Center, Dallas, TX, USA

    3 shared publications
  • David R. Greaves

    Sir William Dunn School of Pathology, University of Oxford, United Kingdom

    1 shared publication
  • Don C. Rockey

    Digestive Diseases, University of Texas Southwestern Medical School, Dallas, TX

    1 shared publication
  • Noredia Ojogun

    Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, TX, USA

    1 shared publication
  • Richard Kitchens

    Department of Internal Medicine, Division of Infectious Diseases, The University of Texas Southwestern Medical Center, Dallas, TX, USA

    1 shared publication
  • Richard L. Kitchens

    Infectious Diseases, University of Texas Southwestern Medical School, Dallas, TX

    1 shared publication

Latest Publications

  • Open Access

    Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes

    by Baomei Shao, Robert S Munford, Richard Kitchens, Alan W Varley

    Much evidence indicates that bacterial LPS (endotoxin) is removed from the bloodstream mainly by the liver, yet the hepatic uptake mechanisms remain uncertain and controversial. In plasma, LPS can be either ‘free’ (as aggregates, bacterial membrane fragments or loosely bound to albumin, CD14, or other proteins) or ‘bound’ (complexed with lipoproteins). Whereas most free LPS is taken up by Kupffer cells (KCs), lipoprotein-bound LPS has seemed to be cleared principally by hepatocytes. Here, we compared the liver’s ability to take up and deacylate free LPS aggregates and the LPS in preformed LPS-high density lipoprotein (HDL) complexes. In mice examined from 1 h to 7 d after a small amount of fluorescent (FITC-)LPS was injected into a lateral tail vein, we found FITC-LPS almost entirely within, or adjacent to, KCs. As expected, FITC-LPS complexed with HDL (FITC-LPS-HDL) disappeared more slowly from the circulation and a smaller fraction of the injected dose of FITC-LPS was found in the liver. Unexpectedly, the FITC-LPS injected as FITC-LPS-HDL complexes was also found within sinusoids, adjacent to, or within, KCs. In other experiments, we found that both free and HDL-bound radiolabeled LPS underwent enzymatic deacylation by acyloxyacyl hydrolase (AOAH), the LPS-inactivating enzyme that is principally produced within the liver by KCs. Our observations suggest that KCs and AOAH play important roles in clearing and catabolizing both free LPS and the LPS in circulating LPS-HDL complexes.


  • Open Access

    Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin

    by Baomei Shao, Richard L. Kitchens, Robert S. Munford, Thomas E. Rogers, Don C. Rockey, Alan W. Varley

    Transient hepatomegaly often accompanies acute bacterial infections. Reversible, dose-dependent hepatomegaly also occurs when animals are given intravenous infusions of bacterial lipopolysaccharide (LPS). We found that recovery from LPS-induced hepatomegaly requires a host enzyme, acyloxyacyl hydrolase (AOAH), that inactivates LPS. When we challenged Aoah −/− mice with low doses of LPS or Gram-negative bacteria, their livers remained enlarged (as much as 80% above normal) many weeks longer than did the livers of Aoah +/+ animals. When compared with livers from LPS-primed Aoah +/+ mice, LPS-primed Aoah −/− livers had (1) more numerous and larger Kupffer cells, (2) intrasinusoidal leukocyte aggregates and activated sinusoidal endothelial cells, and (3) sustained production of interleukin (IL)-10 and messenger RNAs (mRNAs) for tumor necrosis factor (TNF), IL-10, and IRAK-M. Depleting Kupffer cells decreased the liver enlargement by ≈40%, whereas depletion of neutrophils, dendritic cells, natural killer (NK) cells, NK-T cells, or B cells had no effect. Pretreatment with dexamethasone almost completely prevented prolonged hepatomegaly in Aoah −/− mice, whereas neutralizing TNF or interleukin-1β was only partially effective. In contrast, an antagonistic antibody to the IL-10 receptor increased LPS-induced hepatomegaly by as much as 50%. Conclusion: our findings suggest that persistently active LPS induces Kupffer cells to elaborate mediators that promote the accumulation of leukocytes within enlarged sinusoids. Large increases in IL-10 and several other modulatory molecules are unable to prevent prolonged hepatomegaly in mice that cannot inactivate LPS. The striking findings in this mouse model should encourage studies to find out how AOAH contributes to human liver physiology and disease. (HEPATOLOGY 2011;)


  • Open Access

    Overproduction of Acyloxyacyl Hydrolase by Macrophages and Dendritic Cells Prevents Prolonged Reactions to Bacterial Lipopolysaccharide In Vivo

    by Noredia Ojogun, Tang‐Yong Kuang, Baomei Shao, David R. Greaves, Robert S. Munford, Alan W. Varley

    Although recognition of lipopolysaccharide (LPS) by the myeloid differentiation factor 2–Toll-like receptor 4 complex is important for triggering pro